Cross-tapering clozapine and risperidone. 1995

A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper

UI MeSH Term Description Entries
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012563 Schizophrenia, Paranoid A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Delusional Disorder,Paranoid Schizophrenia,Delusional Disorders,Disorder, Delusional,Disorders, Delusional,Paranoid Schizophrenias,Schizophrenias, Paranoid
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug
D018967 Risperidone A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. R-64,766,R-64766,Risperdal Consta,Risperidal,Consta, Risperdal,R 64,766,R 64766,R64,766,R64766

Related Publications

A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
February 2000, The American journal of psychiatry,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
June 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
March 1995, Pharmacopsychiatry,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
January 1999, Indian journal of psychiatry,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
April 2006, The New England journal of medicine,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
April 2006, The New England journal of medicine,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
April 2006, The New England journal of medicine,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
February 2006, The New England journal of medicine,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
May 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
A R Koreen, and J A Lieberman, and M Kronig, and T B Cooper
September 1995, The American journal of psychiatry,
Copied contents to your clipboard!